Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Pear Therapeutics, Inc. - Class A Common Stock
(NQ:
PEAR
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Apr 18, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Pear Therapeutics, Inc. - Class A Common Stock
< Previous
1
2
3
4
5
Next >
Mid-Day Market Update: Nasdaq Rises 1%; Praxis Precision Medicines Shares Plunge
June 06, 2022
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 1% on Monday.
Via
Benzinga
52 Stocks Moving In Monday's Mid-Day Session
June 06, 2022
Gainers DiDi Global Inc. (NYSE: DIDI) jumped 51.4% to $2.80 after the Chinese government said the company can resume adding new users.
Via
Benzinga
Chardan Capital Maintains Buy Rating for Pear Therapeutics: Here's What You Need To Know
May 17, 2022
Chardan Capital has decided to maintain its Buy rating of Pear Therapeutics (NASDAQ:PEAR) and lower its price target from $16.00 to $13.00. Shares of Pear Therapeutics are trading up 9.75% over the...
Via
Benzinga
Earnings Scheduled For May 16, 2022
May 16, 2022
Companies Reporting Before The Bell • AcelRx Pharmaceuticals (NASDAQ:ACRX) is estimated to report quarterly loss at $0.06 per share on revenue of $550.00 thousand.
Via
Benzinga
Read Why BTIG Sees An Upside OF 55% In Pear Therapeutics
January 03, 2022
BTIG
Via
Benzinga
69 Biggest Movers From Friday
June 06, 2022
Gainers Turning Point Therapeutics, Inc. (NASDAQ: TPTX) shares climbed 118.4% to close at $74.59 on Friday after Bristol Myers Squibb announced it will acquire Turning Point Therapeutics for $76 per...
Via
Benzinga
10 Biggest Price Target Changes For Tuesday
May 17, 2022
Citigroup cut the price target on Insulet Corporation (NASDAQ: PODD) from $350 to $310. Insulet shares fell 1.1% to close at $196.91 on Monday.
Via
Benzinga
90 Biggest Movers From Yesterday
May 13, 2022
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) surged 70.5% to close at $0.1330 on Thursday after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered...
Via
Benzinga
58 Stocks Moving In Thursday's Mid-Day Session
May 12, 2022
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 102.6% to $0.1580 after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered direct offering.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
May 11, 2022
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
May 11, 2022
Via
Benzinga
90 Biggest Movers From Yesterday
May 10, 2022
Gainers
Via
Benzinga
51 Biggest Movers From Yesterday
March 31, 2022
Gainers Forge Global Holdings, Inc. (NYSE: FRGE) jumped 73.9% to close at $37.64. Direct Digital Holdings, Inc. (NASDAQ: DRCT) shares surged 60.5% to close at $4.14 on Wednesday...
Via
Benzinga
35 Stocks Moving In Wednesday's Mid-Day Session
March 30, 2022
Gainers Direct Digital Holdings, Inc. (NASDAQ: DRCT) shares jumped 82.6% to $4.71 after the company reported a year over year increase in Q4 sales results and issued Q1 sales...
Via
Benzinga
Where Pear Therapeutics Stands With Analysts
March 29, 2022
Over the past 3 months, 4 analysts have published their opinion on Pear Therapeutics (NASDAQ:PEAR) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding...
Via
Benzinga
Earnings Scheduled For March 28, 2022
March 28, 2022
Companies Reporting Before The Bell • LGL Group (AMEX:LGL) is likely to report quarterly earnings at $0.10 per share on revenue of $7.20 million.
Via
Benzinga
Pear Therapeutics, SoftBank Team On Sleep/Wake Disorder Therapeutic For Japanese Market
March 21, 2022
Pear Therapeutics Inc (NASDAQ: PEAR) has agreed with SoftBank Group Corp (OTC: SFTBY) to develop a Japanese-language digital therapeutic for sleep/wake disorders...
Via
Benzinga
Pear Therapeutics' Digital Therapeutic For Insomnia Shows Meaningful Reductions In Severity Through 6 Months
March 15, 2022
Pear Therapeutics Inc (NASDAQ: PEAR) announced data that further underscore the effectiveness of Somryst for chronic insomnia at the World Sleep 2022.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
March 07, 2022
Gainers TherapeuticsMD (NASDAQ:TXMD) stock moved upwards by 38.1% to $0.29 during Monday's regular session. As of 12:30 EST, TherapeuticsMD's stock is trading at a...
Via
Benzinga
46 Stocks Moving In Thursday's Mid-Day Session
January 27, 2022
Gainers Indonesia Energy Corporation Limited (NASDAQ: INDO) shares jumped 158.2% to $7.23 after tumbling 18% on Wednesday. Indonesia Energy said it projects to commence drilling...
Via
Benzinga
45 Biggest Movers From Yesterday
January 05, 2022
Gainers ATA Creativity Global (NASDAQ: AACG) gained 114.3% to close at $2.55. Hoth Therapeutics, Inc. (NASDAQ: HOTH) surged 85.7% to settle at $1.30 after the company announced...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 26, 2022
January 26, 2022
Upgrades
Via
Benzinga
34 Stocks Moving In Tuesday's Mid-Day Session
January 04, 2022
Gainers TherapeuticsMD, Inc. (NASDAQ: TXMD) jumped 31.7% to $0.5185 after it announced that the FDA approved a low dose version of Bijuva, an oral hormone therapy to treat women...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 20, 2022
January 20, 2022
Upgrades For W.P. Carey Inc (NYSE:WPC), B...
Via
Benzinga
61 Biggest Movers From Yesterday
January 04, 2022
Gainers Genprex, Inc. (NASDAQ: GNPX) shares surged 167.2% to settle at $3.50 on Monday. The FDA granted Fast Track Designation for Genprex’s lead drug candidate, Reqorsa...
Via
Benzinga
Mid-Afternoon Market Update: Dow Surges 150 Points; Applied Therapeutics Shares Slide
January 03, 2022
Toward the end of trading Monday, the Dow traded up 0.43% to 36,496.18 while the NASDAQ rose 0.93% to 15,790.97. The S&P also rose, gaining 0.43% to 4,786.68. The U.S. has the...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
January 03, 2022
Gainers Genprex (NASDAQ:GNPX) stock moved upwards by 117.5% to $2.85 during Monday's regular session. Genprex's stock is trading at a volume of 101.5 million...
Via
Benzinga
Mid-Day Market Update: Gold Down 1%; Immix Biopharma Shares Spike Higher
January 03, 2022
Midway through trading Monday, the Dow traded up 0.18% to 36,402.21 while the NASDAQ rose 0.75% to 15,762.21. The S&P also rose, gaining 0.23% to 4,776.99. The U.S. has the...
Via
Benzinga
35 Stocks Moving In Monday's Mid-Day Session
January 03, 2022
Gainers Immix Biopharma, Inc. (NASDAQ: IMMX) shares climbed 110.3% to $7.32. The FDA granted Rare Pediatric Disease (RPD) designation to newly listed Immix Biopharma's IMX-...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 3, 2022
January 03, 2022
Upgrades For nVent Electric PLC (NYSE:NVT), Vertica...
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.